Head-to-head

Clinical trials for Head-to-head explained in plain language.

Never miss a new study

Get alerted when new Head-to-head trials appear

Sign up with your email to follow new studies for Head-to-head, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a new pill outperform standard care for ulcerative colitis?

Disease control Not yet recruiting

This trial compares two oral medications for active ulcerative colitis, a chronic inflammatory bowel disease causing diarrhea, bleeding, and pain. About 320 Chinese adults will be randomly assigned to take either etrasimod, a newer drug that blocks immune cells from entering the …

Matched conditions: HEAD-TO-HEAD

Phase 4 • Sponsor: Sir Run Run Shaw Hospital • Aim: Disease control

Last updated Aug 26, 2026 00:00 UTC

Head-to-head

Get alerted when new Head-to-head trials appear

Can a new pill outperform standard care for ulcerative colitis?